Health Care ETFs Endure Biotech Slump

When biotechnology stocks soared last year and through the first two plus months of 2014, some astute market observers pointed out that it was not a bad thing that some health care exchange traded funds were establishing roles as market leaders. While traditional health care ETFs such as the Health...